http://www.iGuard.org A summary of the most recent drug safety alerts for prescription medicines. us-en Thu, 4 Sep 2008 00:00:00 EST iGuard RSS generator support@iGuard.org http://www.iGuard.org/alert.html?aid=253 Thu, 4 Sep 2008 00:00:00 EST The FDA recently released an alert to remind patients that tumor necrosis factor-alpha blockers (TNF blockers), such as ETANERCEPT (ENBREL), may increase your risk for infections. This can include serious infections caused by viruses, fungi, or bacteria, http://www.iGuard.org/alert.html?aid=246 Wed, 3 Sep 2008 00:00:00 EST The Institute for Safe Medication Practices (ISMP) recently described an increase in reports about mix-ups between regular insulin U-100 and insulin U-500. Insulin U-100 is the most commonly prescribed concentration of insulin with a concentration of 100 http://www.iGuard.org/alert.html?aid=247 Wed, 3 Sep 2008 00:00:00 EST A recent study published in Drug Safety suggests that taking two different types of cholesterol-lowering drugs, HMG-CoA reductase inhibitors (also called statins) and fibric acid derivatives (also called fibrates) may increase the risk of muscle problems. http://www.iGuard.org/alert.html?aid=244 Tue, 26 Aug 2008 00:00:00 EST The FDA has recently received information about two new cases of progressive multifocal leukoencephalopathy (PML) in patients receiving Tysabri monotherapy for multiple sclerosis in Europe. Although PML and other opportunistic infections are known risks http://www.iGuard.org/alert.html?aid=245 Tue, 26 Aug 2008 00:00:00 EST Shire Pharmaceuticals has voluntarily recalled several lots of DAYTRANA (methylphenidate transdermal system patch), a patch used to treat Attention Deficit Hyperactivity Disorder (ADHD). The recalled patches are from Lot Numbers 2750211, 2764111, 2764211